Two new guanidine alkaloids, 1 and 2, were isolated from the methanol extract of the leaf of Verbesina peraffinis, in addition to four known substances: galegine, the methylamide of caffeic acid, galactitol and the flavonoid 3-O-glucosyl-(1–2)-galactoside-5,7,4′ trimethoxy-kaempferol. Their structures were determined on the basis of spectroscopic methods. The antihypertensive activity of the methanolic extract was assayed in rats using a model of hypertension induced by footshock.
PaneroJL, JansenRK. (1997) Chloroplast DNA restriction site study of Verbesina (Asteraceae: Heliantheae), American Journal of Botany, 84, 382–392.
2.
BadilloVM. (2001) Lista actualizada de Compuestas Venezuela. Ernstia, 11, 147–151
3.
TiwariHP, RaoVS. (1978) Constituents of Verbesina enceloides, isolation of triterpenes from a Verbesina sp. Indian Journal of Chemistry. Section B. Organic Chemistry, Including Medicinal Chemistry, 16, 1133.
Amaro-LuisJM, RamirezI, Delgado-MendezP, JorgeZD. (2002) Eudesmane derivatives from Verbesina turbacensis. Journal of the Brazilian Chemical Society, 13, 352–357.
EichholzerJV, LewisIAS, MacleodJK, OelrichsPB, VallelyPJ. (1982) Galegine a new dihidroxyalkylacetamide from Verbesina encelioides. Phytochemistry, 21, 97–100.
8.
Delle MonacheG, BottaB, Delle MonacheF, EspinalR, De BonnevauxSC, De LucaC, BottaM, CorelliF, CarmignaniM. (1992) Hypotensive agents from Verbesina caracasana. Bioorganic and Medicinal Chemistry Letters, 2, 415–418.
9.
Delle MonacheG, BottaB, Delle MonacheF, EspinalR, De BonnevauxSC, De LucaC, BottaM, CorelliF, DeiD, CarmignaniM. (1996) Caracasadiamide, a truxinic hypotensive agents from Verbesina caracasana. Biorganic and Medicinal Chemistry Letters, 6, 233–238.
10.
Delle MonacheG, BottaB, Delle MonacheF, EspinalR, De BonnevauxSC, De LucaC, BottaM, CorelliF, CarmignaniM. (1993) Novel hypotensive agents from Verbesina caracasana 2. Synthesis and pharmacology of caracasanamide. Journal of Medicinal Chemistry, 36, 2956–2963.
11.
SorkinEM, HeelRC. (1986) Guanfacine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of hypertension. Drugs, 31, 301–336.
12.
WebbCE, EllistonEB. (1976) Guanethidine, therapy of hypertension. Journal of Family Practice, 3, 348.
13.
DavidT, NashMD. (1973) Clinical trial with guanabenz, a new antihypertensive agent. Journal of Clinical Pharmacology and New Drugs, 13, 416–421.
14.
LeeJ, KonarskaM, McCartyR. (1983) Physiological responses to acute stress in alloxan and streptozotocin diabetic rats. Physiological Behaviour, 45, 483–489.
15.
WellsWW, PittmanTA, WellsHJ, EganTJ. (1965) The isolation and identification of galactitol from the brains of galactosemia patients. Journal of Biological Chemistry, 240, 1002–1004.
16.
RajanP, VedernikovaI, CosP, BergheDV, AugustynsK, HaemersA. (2001) Synthesis and evaluation of caffeic acid amides as antioxidants. Biorganic and Medicinal Chemistry Letters, 11, 215–217.
17.
AgrawalPK. (1989) Carbon-13 NMR of Flavonoids, Elsevier, Amsterdam.
18.
OelrichsPB, VallelyPJ, MacLeodJK, LewisAS. (1981) Isolation of galegine from Verbesine enceloides. Journal of Natural Products, 44, 754–756
19.
IsraelA, Sosa-CanacheB. (2002) Angiotensin II supports sympathetically mediated vasopressor response to footshock-stress. Journal of Human Hypertension, 16, 84–88.
20.
LitchifieldJ, WilcoxonF. (1949) A simple method of evaluating dose-effect experiments. Journal of Pharmacology Experimental Therapeutic, 96, 99–113.
